Neuberger Berman Group’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Neuberger Berman Group’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,000	Closed	-$9K	–	1709
2014 Q3	$9K	Hold	1,000	–	–	﹤0.01%	1639
2014 Q2	$10K	Hold	1,000	–	–	﹤0.01%	1701
2014 Q1	$14K	Hold	1,000	–	–	﹤0.01%	1606
2013 Q4	$23K	Hold	1,000	–	–	﹤0.01%	1608
2013 Q3	$31K	Hold	1,000	–	–	﹤0.01%	1599
2013 Q2	$32K	Buy	+1,000	New	+$34.4K	﹤0.01%	1569

Other funds holding STAB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Neuberger Berman Group's STAB Position: Q4 2014 in Review

Neuberger Berman Group sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2014, closing a stake of 1,000 shares — an estimated $9K sold.

Neuberger Berman Group first reported a position in STAB in Q2 2013 and held it in 6 quarters. The position peaked at $32K in Q2 2013. 24 funds tracked by Wall St. Rank hold STAB as of Q4 2014.

Neuberger Berman Group reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
Neuberger Berman Group sold 1,000 Statera Biopharma, Inc. Common Stock shares in Q4 2014, an estimated $9K.
Neuberger Berman Group first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 6 quarters.
Neuberger Berman Group's Statera Biopharma, Inc. Common Stock position peaked at $32K in Q2 2013.
24 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2014.

Based on Neuberger Berman Group's 13F filing for Q4 2014, filed 5 Feb 2015.